Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 212007
Company: EXELA PHARMA
Company: EXELA PHARMA
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
ZINC CHLORIDE | ZINC CHLORIDE | EQ 1MG ZINC/ML | INJECTABLE;INJECTION | Prescription | AP | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
05/21/2021 | ORIG-1 | Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/212007Orig1s000ltr.pdf |
ZINC CHLORIDE
INJECTABLE;INJECTION; EQ 1MG ZINC/ML
TE Code = AP
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
ZINC CHLORIDE | ZINC CHLORIDE | EQ 1MG ZINC/ML | INJECTABLE;INJECTION | Prescription | No | AP | 212007 | EXELA PHARMA |
ZINC CHLORIDE IN PLASTIC CONTAINER | ZINC CHLORIDE | EQ 1MG ZINC/ML | INJECTABLE;INJECTION | Prescription | Yes | AP | 018959 | HOSPIRA |